EXPO Pengajuan SEC - Exponent, Inc.- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	529900NY3F5Q2NWPUZ42
CIK	851520

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Exponent, Inc.

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

August 8, 2025	10-Q	For the Three and Six Months Ended July 4, 2025 and June 28, 2024 For the Three and Six Months Ended July 4, 2025 and June 28, 2024 For the Three and Six Months Ended July 4, 2025 and June 28, 2024 For the Three and Six Months Ended July 4, 2025 and UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 4, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC.
July 31, 2025	EX-99.1	Exponent Reports Second Quarter 2025 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2025 Financial Results MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2025 ended July 4, 2025. “Second quarter revenues were flat but exceeded expectations, reflecting our team’s disciplined execution and resilience in this dynamic environment,” st
July 31, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 Exponent, Inc. (Exa UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
July 31, 2025	EX-99.2	Exponent Declares Regular Quarterly Dividend for Q3 2025 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q3 2025 MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on September 19, 2025, to all common stockholders of record as of September 5, 2025. Exponent has paid, and expects to
June 10, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Exponent, Inc. (Exac UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 9, 2025	10-Q	For the Three Months Ended April 4, 2025 and March 29, 2024 For the Three Months Ended April 4, 2025 and March 29, 2024 Condensed Consolidated Statements of Cash Flows For the Three Months Ended April 4, 2025 and March 29, 2024 Note 7: Supplemental C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
May 1, 2025	EX-99.1	Exponent Reports First Quarter 2025 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2025 Financial Results MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2025 ended April 4, 2025. “Exponent’s first quarter results exceeded expectations, reinforcing both the resilience of our diversified business model and the value we deliver,” said
May 1, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (
May 1, 2025	EX-99.2	Exponent Declares Regular Quarterly Dividend for Q2 2025 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q2 2025 MENLO PARK, Calif., May 01, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on June 20, 2025 to all common stockholders of record as of June 6, 2025. Exponent has paid, and expects to continue to
April 21, 2025	DEF 14A	AUDIT COMMITTEE REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS COMPENSATION DISCUSSION AND ANALYSIS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
April 18, 2025	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2025. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT,
February 28, 2025	EX-19.1	Insider Trading Policy Exhibit 19.1 Exponent, Inc. Policy on Transactions in Company Securities and procedures governing “Insider Trading” (as amended through October 1, 2016) 1. Purpose of Policy This Policy describes the responsibility of employees, officers and members of the board of directors of EXPONENT, INC. (the "Company") to comply with the laws governing securities transactions. In addition, the Company has es
February 28, 2025	EX-3.1(II)	Certificate of Amendment of Restated Certificate of Incorporation dated January 30, 1998. Exhibit 3.1(ii) STATE OF DELAWARE SECRETARY OF STATE DIVISION OF CORPORATIONS FILED 04:30 PM 01/30/1998 981039836 - 2195846 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF THE FAILURE GROUP, INC. THE FAILURE GROUP, INC., a corporation organized and existing under and by virtue of General Corporation Law of the State of Delaware (the "General Corporation Law"). does hereby cert
February 28, 2025	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone
February 28, 2025	EX-97.0	Exponent, Inc. Incentive Compensation Recovery Policy Exhibit 97.01 EXPONENT, INC. 2023 Clawback Policy Effective October 2, 2023 Purpose As required pursuant to the listing standards of the Nasdaq Stock Market LLC (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Board of Directors (the “Board”) of Exponent, Inc. (the “Company”) has adopted this 202
February 28, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2025. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name
February 28, 2025	EX-FILING FEES	Filing Fee Table EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) Exponent, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule (2) Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee (3) Equity Common Stock $0.001 p
February 28, 2025	S-8	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 EXPONENT, INC. (Exact Name of Registrant as Specified in its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EXPONENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0218904 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 149 Commonwealth Drive, Menlo Park, California 94025 (Address of Principa
February 6, 2025	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.28 to $0.30 per Share for Q1 2025 EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.28 to $0.30 per Share for Q1 2025 MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The quarterly cash dividend of $0.30 per share of common stock is to be paid on March
February 6, 2025	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2025 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
February 6, 2025	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2024 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2024 Financial Results MENLO PARK, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2024 ended January 3, 2025. "Our fourth quarter results exceeded expectations, capping off a solid year that demonstrated the resilience of the business. With a
November 1, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
November 1, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 24, 2024	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2024 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2024 Financial Results MENLO PARK, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2024 ended September 27, 2024. “For the third consecutive quarter Exponent has delivered significantly improved utilization year over year, reflecting our ongoing fo
October 24, 2024	EX-99.2	Exponent Declares Regular Quarterly Dividend for Q4 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q4 2024 MENLO PARK, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on December 20, 2024 to all common stockholders of record as of December 6, 2024. Exponent has paid, and expects to co
October 24, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
October 3, 2024	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 16)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is
August 2, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
July 25, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
July 25, 2024	EX-99.1	Exponent Reports Second Quarter 2024 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2024 Financial Results MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2024 ended June 28, 2024. “We are pleased with the outcomes of efforts to align our operating model with market demand, evidenced by net income growth of 14% and expanded EBITDA1
July 25, 2024	EX-99.2	Exponent Declares Regular Quarterly Dividend for Q3 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q3 2024 MENLO PARK, Calif., July 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on September 20, 2024, to all common stockholders of record as of September 6, 2024. Exponent has paid, and expects to
June 24, 2024	EX-10.1	Notice of Election to Extend Lease between the Company and the Arizona State Land Department (incorporated by reference from the Company's Current Report on Form 8-k as filed on Jun 24, 2024) Exhibit 10.1 June 5, 2024 Arizona State Land Department 1110 W Washington Street Phoenix, Arizona 85007 Attention: James Perry Deputy State Land Commissioner Re: Notice of election to extend the Lease term under that certain Commercial Lease No. 03‑53542 dated January 17, 1998 (the “Lease”), by and between Failure Analysis Associates, Inc., as predecessor-in-interest to Exponent of Delaware Inc.,
June 24, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
June 11, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 06, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 3, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN
April 25, 2024	EX-99.1	Exponent Reports First Quarter 2024 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2024 Financial Results MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2024 ended March 29, 2024. “Exponent delivered better than expected results in the first quarter, as we grew revenues before reimbursements 7% and expanded earnings per share year
April 25, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
April 25, 2024	EX-99.2	Exponent Declares Regular Quarterly Dividend for Q2 2024 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend for Q2 2024 MENLO PARK, Calif., April 25, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common stock to be paid on June 21, 2024 to all common stockholders of record as of June 7, 2024. Exponent has paid, and expects to continue
April 22, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 22, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
April 17, 2024	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2023. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONEN
April 10, 2024	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0013-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 14)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: March 28, 2024 Check the appropriate box to designate the rule pur
March 1, 2024	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
February 23, 2024	EX-97.0	Exponent, Inc. Incentive Compensation Recovery Policy Exhibit 97.01 EXPONENT, INC. 2023 Clawback Policy Effective October 2, 2023 Purpose Asrequired pursuant to the listing standards of the Nasdaq Stock Market LLC (the “Stock Exchange”), Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rule 10D-1 under the Exchange Act, the Board of Directors (the “Board”) of Exponent, Inc. (the “Company”) has adopted this 2023
February 23, 2024	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone
February 23, 2024	EX-3.1(II)	Certificate of Amendment of Restated Certificate of Incorporation dated January 30, 1998. Exhibit 3.1(ii) STATE OF DELAWARE SECRETARY OF STATE DIVISION OF CORPORATIONS FILED 04:30 PM 01/30/1998 981039836 - 2195846 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF THE FAILURE GROUP, INC. THE FAILURE GROUP, INC., a corporation organized and existing under and by virtue of General Corporation Law of the State of Delaware (the "General Corporation Law"). does hereby cert
February 23, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2023. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 13, 2024	SC 13G/A	EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0086862-20sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Da
February 13, 2024	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0899-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 13)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule
February 12, 2024	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC Passive Investment SC 13G/A 1 formsc13ga-02122024080255.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 15)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
February 8, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 02, 2024 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
February 1, 2024	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.26 to $0.28 per Share for Q1 2024, Increases Stock Repurchase Authorization to $100 Million EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.26 to $0.28 per Share for Q1 2024, Increases Stock Repurchase Authorization to $100 Million MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.26 to $0.28 per share of common stock. The quarterly cash dividend of $0
February 1, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2024 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
February 1, 2024	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2023 Financial Results MENLO PARK, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2023 ended December 29, 2023. “Exponent’s world class team of experts delivered a 7% increase in net revenues in 2023, advising clients across industries with a
January 5, 2024	SC 13G/A	EXPO / Exponent, Inc. / Conestoga Capital Advisors, LLC - CONESTOGA CAPITAL ADVISORS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Exponent, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh
November 20, 2023	CORRESP	149 Commonwealth Drive Exponent 149 Commonwealth Drive Menlo Park, CA 94025 telephone 650-326-9400 facsimile 650-326-8072 www.
November 3, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 30, 2023	CORRESP	149 Commonwealth Drive Exponent 149 Commonwealth Drive Menlo Park, CA 94025 telephone 650-326-9400 facsimile 650-326-8072 www.
October 26, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
October 26, 2023	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2023 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2023 Financial Results MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2023 ended September 29, 2023. “Our third quarter results exemplify the durability of our diversified portfolio, which delivered growth in nearly every industry we s
October 26, 2023	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on December 22, 2023 to all common stockholders of record as of December 8, 2023. Exponent has paid, and expects to continue to pa
October 6, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 02, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
September 11, 2023	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) E UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 June 8, 2023 Date of Report (Date of earliest event reported) Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commi
August 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
July 27, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 27, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
July 27, 2023	EX-99.2	Exponent Declares Quarterly Dividend for Q3 2023 EXHIBIT 99.2 Exponent Declares Quarterly Dividend for Q3 2023 MENLO PARK, Calif., July 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on September 22, 2023, to all common stockholders of record as of September 8, 2023. Exponent has paid, and expects to continu
July 27, 2023	EX-99.1	Exponent Reports Second Quarter 2023 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2023 Financial Results MENLO PARK, Calif., July 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2023 ended June 30, 2023. “Exponent delivered solid second quarter results, growing revenues before reimbursements by 10% on a year-over-year basis and expanding earnings per dil
June 13, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 08, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 5, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN
April 27, 2023	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on June 23, 2023 to all common stockholders of record as of June 9, 2023. Exponent has paid, and expects to continue to pay, quart
April 27, 2023	EX-99.1	Exponent Reports First Quarter 2023 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2023 Financial Results MENLO PARK, Calif., April 27, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2023 ended March 31, 2023. “Exponent had a solid start to the year, growing revenues by over 9% on a year-over-year basis. This is a testament to the strength and resiliency of ou
April 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Exponent, Inc. (Ex UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
April 25, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 24, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
February 24, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 30, 2022. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 24, 2023	EX-21	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Expone
February 17, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2023 EXPONENT, INC. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
February 14, 2023	SC 13G/A	EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
February 10, 2023	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment SC 13G/A 1 doc1.htm NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 14)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w
February 9, 2023	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0876-exponentinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 12)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule
February 2, 2023	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.24 to $0.26 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.24 to $0.26 per Share MENLO PARK, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has raised its quarterly dividend from $0.24 to $0.26 per share of common stock. The quarterly cash dividend of $0.26 per share of common stock is to be paid on March 24, 2023 to all c
February 2, 2023	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2022 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2022 Financial Results MENLO PARK, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2022 ended December 30, 2022. “Exponent concluded 2022 with solid results, reflecting broad-based strength across our diversified portfolio of services. In a yea
February 2, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2023 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
December 19, 2022	EX-3.1	Amended and Restated Bylaws of the Company, as amended and restated December 15, 2022 (incorporated by reference from the Company’s Current Report on Form 8-K as filed on December 19, 2022). EXHIBIT 3.1 Amended and Restated Bylaws of Exponent, Inc. (As amended and restated on December 15, 2022) Article I Offices Section 1.1 Registered Office. The registered office of Exponent, Inc. (hereafter called the “Corporation”) in the State of Delaware shall be as determined by the Corporation’s Board of Directors (the “Board”) from time to time. The registered agent of the Corporation at such
December 19, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 Exponent, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 16, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
November 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 27, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
October 27, 2022	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on December 23, 2022 to all common stockholders of record as of December 9, 2022. Exponent has paid, and expects to continue to pay
October 27, 2022	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2022 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2022 Financial Results MENLO PARK, Calif., Oct. 27, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2022 ended September 30, 2022. ?Exponent delivered solid results in the third quarter of 2022, achieving another quarter of year-over-year growth across revenue, EBI
August 5, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC.
July 28, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 28, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
July 28, 2022	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on September 23, 2022 to all common stockholders of record as of September 9, 2022. Exponent has paid, and expects to continue to p
July 28, 2022	EX-99.1	Exponent Reports Second Quarter 2022 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter 2022 Financial Results MENLO PARK, Calif., July 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2022 ended July 1, 2022. ?Exponent delivered solid second quarter results, advancing our long-term strategy and reinforcing our strong financial position. Our business model cont
June 3, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2022 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 6, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 1, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
April 28, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
April 28, 2022	EX-99.1	Exponent Reports First Quarter 2022 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter 2022 Financial Results MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2022 ended April 1, 2022. ?We are pleased to report year-over-year growth in revenue and EBITDA1, once again demonstrating the strength of our business model and our ability to ex
April 28, 2022	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 28, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.24 per share of common stock to be paid on June 24, 2022 to all common stockholders of record as of June 10, 2022. Exponent has paid, and expects to continue to pay, quar
April 20, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
April 20, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
February 25, 2022	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Scie
February 25, 2022	EX-10.18	Amended and Restated Nonqualified Deferred Compensation Plan dated January 1, 2022 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021) Exhibit 10.18 Exponent, Inc. Nonqualified Deferred Compensation Plan Adoption Agreement Table of Contents 1.01 Preamble 1 1.02 Plan 1 1.03 Plan Sponsor 1 1.04 Employer 2 1.05 Administrator 2 1.06 Key Employee Determination Dates 2 2.01 Participation 3 3.01 Compensation 4 3.02 Bonuses 5 4.01 Participant Contributions 6 5.01 Employer Contributions 9 6.01 Distributions 12 7.01 Vesting 16 8.01 Unfores
February 25, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021. OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 22, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
February 22, 2022	EX-99.1	Exponent Increases Share Repurchase Authorization by $150 Million EXHIBIT 99.1 Exponent Increases Share Repurchase Authorization by $150 Million MENLO PARK, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors approved a $150 million expansion of its share repurchase program, adding to the $29.5 million that remains available under the current authorization for repurchases. In total, the Company now ha
February 11, 2022	SC 13G	EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* EXPONENT INC (Name of Issuer) Common Stock (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul
February 11, 2022	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil
February 10, 2022	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 11)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ??Rule
February 3, 2022	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2021 Financial Results MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2021 ended December 31, 2021. ?We finished the year strong, highlighting the exceptional performance of our team and resiliency of our business model. For the fu
February 3, 2022	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.20 to $0.24 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.20 to $0.24 per Share MENLO PARK, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has raised its quarterly dividend by 20% from $0.20 to $0.24 per share of common stock. The quarterly cash dividend of $0.24 per share of common stock is to be paid on March 25, 2022 to
February 3, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2022 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Numb
November 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 1, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, I
October 28, 2021	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on December 17, 2021 to all common stockholders of record as of December 3, 2021. Exponent has paid, and expects to continue to pay
October 28, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
October 28, 2021	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the third quarter of fiscal year 2021 ended October 1, 2021. ?Our differentiated capabilities, which marry high-quality data analytics with deep subject matter expertise, drove continued outperforma
August 6, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 2, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC.
July 29, 2021	EX-99.1	Exponent Reports Second Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2021 ended July 2, 2021. ?During the second quarter, we saw broad-based strength across the business as pandemic-related restrictions eased, which supported a robu
July 29, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (
July 29, 2021	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on September 24, 2021 to all common stockholders of record as of September 10, 2021. Exponent has paid, and expects to continue to
June 7, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2021 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 7, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 2, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
April 29, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
April 29, 2021	EX-99.1	Exponent Reports First Quarter of Fiscal Year 2021 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2021 Financial Results MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2021 ended April 2, 2021. ?Our business continued to gain momentum, driving strong quarterly results which exceeded our prior expectations. In the first quarter, net
April 29, 2021	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock to be paid on June 25, 2021 to all common stockholders of record as of June 11, 2021. Exponent has paid, and expects to continue to pay, quar
April 21, 2021	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State
February 26, 2021	EX-10.38	Exponent, Inc. 401(k) Savings Plan, as amended and restated effective January 1, 2014 (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2021). Exhibit 10.38 EXPONENT, INC 401(k) SAVINGS PLAN (As Amended and Restated Effective January 1, 2014) TABLE OF CONTENTS Page ARTICLE I. INTRODUCTION 1 ARTICLE II. DEFINITIONS 2 2.1 Account 2 2.2 Adjustment Factor 2 2.3 Administrator 2 2.4 Beneficiary 2 2.5 Board 2 2.6 Break in Service 2 2.7 Code 2 2.8 Committee 2 2.9 Company 2 2.10 Compensation 2 2.11 Contributions 3 2.12 Disability 3 2.13 Early Ret
February 26, 2021	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting (Canada) Inc. Canada Exponent Consulting PTE. Ltd. Singapore Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Scie
February 26, 2021	EX-10.39	First Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2021). Exhibit 10.39 FIRST AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the ?Company?) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to reflect the Plan?s compliance with certain requirements of the Internal Revenue Code; and WH
February 26, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 1, 2021. OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name
February 26, 2021	EX-10.40	Second Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014) (incorporated by reference from the Company’s Annual Report on Form 10-K for the fiscal year ended January 1, 2021). Exhibit 10.40 SECOND AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the ?Company?) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to make certain changes regarding hardship withdrawals; and WHEREAS, the Company retains the r
February 12, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* EXPONENT INC (Name of Issuer) (Title of Class of Securities) (CUSIP Number) December 31, 2020 (Date of Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Exponent Inc. Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule
February 4, 2021	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.19 to $0.20 per Share EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.19 to $0.20 per Share MENLO PARK, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.20 per share of common stock to be paid on March 26, 2021 to all common stockholders of record
February 4, 2021	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2021 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
February 4, 2021	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2020 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2020 Financial Results MENLO PARK, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year 2020 ended January 1, 2021. “In a year of worldwide challenge, we demonstrated the durability of Exponent’s business model and
November 25, 2020	CORRESP	- November 25, 2020 VIA EDGAR Mr. Blaise Rhodes Mr. Rufus Decker U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, NE Washington, D.C. 20549 Re: Exponent, Inc. Form 10-K for the Fiscal Year Ended January 3, 2020 Filed February 28, 2020 File No. 000-18655 Dear Messrs. Rhodes and Decker: Exponent, Inc., a Delaware corporation (the “Company
November 6, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 2, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, I
October 29, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
October 29, 2020	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2020 Financial Results EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter of fiscal year 2020 ended October 2, 2020. “We are pleased with the improvements that we have seen across our business and believe that our third quarter results demonstrate resilie
October 29, 2020	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The quarterly cash dividend of $0.19 per share of common stock is to be paid on December 18, 2020 to all common stockholders of record as of
October 27, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2020 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Num
August 10, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC.
July 30, 2020	EX-99.1	Exponent Reports Second Quarter of Fiscal Year 2020 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter of fiscal year 2020 ended July 3, 2020. “We are pleased with the responsiveness of our employees and the adaptiveness of our company to today’s
July 30, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (
July 30, 2020	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock. The Company also announced that the Board of Directors has authorized an additional $45 million for stock
May 29, 2020	8-K	Regulation FD Disclosure, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2020 Exponent, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 0-018655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
May 8, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 3, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
May 6, 2020	DEFA14A	- DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State
April 30, 2020	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 per share of common stock to be paid on June 26, 2020 to all common stockholders of record as of June 12, 2020. Exponent has paid, a
April 30, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
April 30, 2020	EX-99.1	Exponent Reports First Quarter of Fiscal Year 2020 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2020 Financial Results MENLO PARK, Calif., April 30, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2020 ended April 3, 2020. “We are pleased to report another strong first quarter with year over year growth in revenues and earnings. Business restrictions related
April 15, 2020	DEF 14A	EXPO / Exponent, Inc. DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State
February 28, 2020	EX-4.2	Description of the Registrant’s Securities (incorporated by reference from the Company’s Annual Report on From 10-K for fiscal year ended January 1, 2021). Exhibit 4.2 DESCRIPTION OF REGISTRANT’S SECURITIES The following brief description of the capital stock of Exponent, Inc. (“us”, “our”, “we”, or the “Company”), is a summary. This summary is not complete and is subject to and qualified in its entirety by reference to the complete text of our Restated Certificate of Incorporation (“Certificate of Incorporation”) and our Amended and Restated By-Laws
February 28, 2020	EX-10.40	Second Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014). Exhibit 10.40 SECOND AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the “Company”) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to make certain changes regarding hardship withdrawals; and WHEREAS, the Company retains the r
February 28, 2020	EX-10.39	First Amendment to the Exponent, Inc. 401(k) Savings Plan (as amended and restated January 1, 2014). Exhibit 10.39 FIRST AMENDMENT TO THE EXPONENT, INC. 401(k) SAVINGS PLAN (AS AMENDED AND RESTATED JANUARY 1, 2014) WHEREAS, Exponent, Inc. (the “Company”) adopted an amended and restated 401(k) Savings Plan effective January 1, 2014 (the "Plan"); and WHEREAS, the Company wishes to amend the Plan in order to reflect the Plan’s compliance with certain requirements of the Internal Revenue Code; and WH
February 28, 2020	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting PTE. Ltd. Singapore Exponent GmbH Germany Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Science and Technology
February 28, 2020	EX-10.38	Exponent, Inc. 401(k) Savings Plan, as amended and restated effective January 1, 2014. EX-10.38 3 expo-ex1038303.htm EX-10.38 2014 PLAN Exhibit 10.38 EXPONENT, INC 401(k) SAVINGS PLAN (As Amended and Restated Effective January 1, 2014) TABLE OF CONTENTS Page ARTICLE I. INTRODUCTION 1 ARTICLE II. DEFINITIONS 2 2.1 Account 2 2.2 Adjustment Factor 2 2.3 Administrator 2 2.4 Beneficiary 2 2.5 Board 2 2.6 Break in Service 2 2.7 Code 3 2.8 Committee 3 2.9 Company 3 2.10 Compensation 3 2.11
February 28, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended January 3, 2020. OR ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact name
February 12, 2020	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2019 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 1
February 12, 2020	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc
February 6, 2020	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.16 to $0.19 per Share EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.16 to $0.19 per Share MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.19 per share of common stock to be paid on March 27, 2020 to all common stockholders of record as of March 13, 2020. “In 2019, we
February 6, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2020 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
February 6, 2020	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2019 Financial Results MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year 2019 ended January 3, 2020. “The fourth quarter was exceptional and concluded a strong 2019 for Exponent. For the quarter and y
January 17, 2020	SC 13G	EXPO / Exponent, Inc. / Conestoga Capital Advisors, LLC - CONESTOGA CAPITAL ADVISORS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Exponent, Inc. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2019 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i
November 1, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 27, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 17, 2019	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter of fiscal year 2019 ended September 27, 2019. “Exponent reported high-single digit net revenue growth during the third quarter, representing conti
October 17, 2019	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on December 20, 2019 to all common stockholders of record as of December 6, 2019. Exponent has p
October 17, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2019 EXPONENT INC (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number
August 2, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
July 18, 2019	EX-99.1	Exponent Reports Second Quarter of Fiscal Year 2019 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., July 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter of fiscal year 2019 ended June 28, 2019. “Exponent delivered strong second quarter results with double digit growth in revenues and profits. As
July 18, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 18, 2019 EXPONENT INC (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.
July 18, 2019	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on September 20, 2019 to all common stockholders of record as of September 6, 2019. Exponent has
June 3, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 30, 2019 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission file numbe
May 3, 2019	10-Q	Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 29, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN
April 18, 2019	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common stock to be paid on June 21, 2019 to all common stockholders of record as of June 7, 2019. Exponent has paid, an
April 18, 2019	EX-99.1	Exponent Reports First Quarter of Fiscal Year 2019 Financial Results EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2019 Financial Results MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2019 ended March 29, 2019. “Exponent’s first quarter of 2019 built on its positive momentum from 2018. In line with our prior expectations, we achieved low-single di
April 18, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 18, 2019 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I
April 16, 2019	DEF 14A	EXPO / Exponent, Inc. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
February 22, 2019	EX-21.1	List of subsidiaries. EX-21.1 2 tv512970ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent Consulting PTE. Ltd. Singapore Exponent GmbH Germany Exponent International Engineering and Scientific Consulting Limited Ireland Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC
February 22, 2019	10-K	EXPO / Exponent, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 28, 2018. OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 13, 2019	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc
February 11, 2019	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designat
January 31, 2019	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.13 to $0.16 per Share and Adds $75 Million to Stock Repurchase Authorization EXHIBIT 99.2 Exponent Increases Quarterly Dividend Payment from $0.13 to $0.16 per Share and Adds $75 Million to Stock Repurchase Authorization MENLO PARK, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that it has raised its quarterly dividend by 23% from $0.13 to $0.16 per share of common stock and has authorized an additional $75 million for stock repurcha
January 31, 2019	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 31, 2019 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
January 31, 2019	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2018 Financial Results MENLO PARK, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year ended December 28, 2018. “2018 was another year of solid growth for Exponent. We posted high-single digit revenue growth, expan
December 10, 2018	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: November 30, 2018 Check the appropriate box to designat
November 2, 2018	10-Q	EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 28, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 18, 2018	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per share of common stock to be paid on December 21, 2018 to all common stockholders of record as of December 7, 2018. Exponent has p
October 18, 2018	EX-99.1	Exponent Reports Third Quarter of Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter ended September 28, 2018. “Exponent posted high-single digit revenue and EBITDA1 growth reflecting strong demand for our expertise during the thir
October 18, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 18, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
August 3, 2018	EX-3.1	Restated Certificate of Incorporation, as amended effective May 31, 2018. Exhibit 3.1 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF EXPONENT, INC. Exponent, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: Paragraph (A) of Article Fourth of the Corporation’s Restated Certificate of Incorporation is hereby amended and restated to r
August 3, 2018	10-Q	EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 29, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
July 19, 2018	EX-99.1	Exponent Reports Second Quarter of Fiscal Year 2018 Financial Results EXHIBIT 99.1 Exponent Reports Second Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., July 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter ended June 29, 2018. “Exponent delivered high-single digit revenue growth in the quarter and continued to expand margins, contributing to a strong first half of 2018. Exponent’s r
July 19, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 19, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
July 19, 2018	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.13 per share of common stock to be paid on September 21, 2018 to all common stockholders of record as of September 7, 2018. Exponent has
May 31, 2018	EX-99.2	Exponent Announces Two-for-One Stock Split EX-99.2 4 tv495574e99-2.htm EXHIBIT 99.2 Exhibit 99.2 Exponent Announces Two-for-One Stock Split MENLO PARK, Calif., May 31, 2018 Exponent, Inc. (Nasdaq:EXPO) today announced that its stockholders have approved a two-for-one stock split of its common stock and a change in the number of authorized shares of common stock to 120 million. On June 7, 2018, each stockholder of record at the close of bus
May 31, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 31, 2018 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Number) (
May 31, 2018	EX-99.1	Exponent Announces Executive Transition Board of Directors appoints Catherine Corrigan as Chief Executive Officer and Paul R. Johnston as Executive Chairman EX-99.1 3 tv495574e99-1.htm EXHIBIT 99.1 Exhibit 99.1 Exponent Announces Executive Transition Board of Directors appoints Catherine Corrigan as Chief Executive Officer and Paul R. Johnston as Executive Chairman MENLO PARK, CA, May 31, 2018 - Exponent, Inc. (NASDAQ: EXPO) today announced that its Board of Directors appointed Dr. Catherine Corrigan, 49, as its Chief Executive Officer and President,
May 31, 2018	EX-3.1	Certificate of Amendment of Restated Certificate of Incorporation of the Company (incorporated by reference from the Company’s Current Report on Form 8-K filed on May 31, 2018). EX-3.1 2 tv495574ex3-1.htm EXHIBIT 3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF EXPONENT, INC. Exponent, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify: FIRST: Paragraph (A) of Article Fourth of the Corporation’s Restated Certificate of Incorporat
May 15, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 15, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R
May 15, 2018	EX-99.1	Exponent Announces Two-for-One Stock Split EXHIBIT 99.1 Exponent Announces Two-for-One Stock Split MENLO PARK, Calif., May 15, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has approved a two-for-one stock split of its common stock and a change in the number of authorized shares of common stock to 120 million, each subject to stockholder approval of both the split and the change in authori
May 4, 2018	10-Q	EXPO / Exponent, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
April 19, 2018	EX-99.2	Exponent Declares Regular Quarterly Dividend EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.26 per share of common stock to be paid on June 22, 2018 to all common stockholders of record as of June 8, 2018. Exponent has paid, and expects to continue to pay, quart
April 19, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 19, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I
April 19, 2018	EX-99.1	Exponent Reports First Quarter of Fiscal Year 2018 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2018 Financial Results MENLO PARK, Calif., April 19, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter ended March 30, 2018. “Exponent continued its strong momentum from 2017 into the first quarter of 2018. We delivered double-digit revenue growth
April 17, 2018	DEF 14A	EXPO / Exponent, Inc. DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
April 6, 2018	PRE 14A	EXPO / Exponent, Inc. PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State
March 19, 2018	S-8	EXPO / Exponent, Inc. S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 EXPONENT, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 77-0218904 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 149 Commonwealth Drive, Menlo Park, California 94025 (Address of Principa
February 23, 2018	EX-21.1	List of subsidiaries. Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent GmbH Germany Exponent International Ltd. United Kingdom Exponent Limited Hong Kong Exponent Realty LLC Delaware Exponent Science and Technology Consulting (Shanghai) Co., Ltd. China
February 23, 2018	10-K	EXPO / Exponent, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 29, 2017. OR ¨ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 15, 2018	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 9)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch
February 9, 2018	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designat
February 1, 2018	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 1, 2018 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
February 1, 2018	EX-99.1	Exponent Reports Fourth Quarter and Fiscal Year 2017 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter and Fiscal Year 2017 Financial Results MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year ended December 29, 2017. “We are pleased with our performance in the fourth quarter and full year 2017 as we delivered strong f
February 1, 2018	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.21 to $0.26 per Share EX-99.2 3 exh992.htm PRESS RELEASE Exhibit 99.2 Exponent Increases Quarterly Dividend Payment from $0.21 to $0.26 per Share MENLO PARK, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared an increased quarterly cash dividend of $0.26 per share of common stock to be paid on March 23, 2018 to all common stockholders of record
December 8, 2017	EX-99.1	Exponent Announces 2018 Succession Plan EdgarFiling EXHIBIT 99.1 Exponent Announces 2018 Succession Plan MENLO PARK, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) announced that its Board of Directors intends to appoint Exponent?s President, Dr. Catherine Ford Corrigan, 49, as its Chief Executive Officer and President at its board meeting following the annual shareholder meeting on May 31, 2018. Exponent?s curren
December 8, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): December 7, 2017 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
November 3, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 29, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 18, 2017	EX-99.1	Exponent Reports Third Quarter Fiscal Year 2017 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter Fiscal Year 2017 Financial Results MENLO PARK, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter ended September 29, 2017. “Exponent’s third quarter results exceeded our expectations. The large human factors assessment project that we previously
October 18, 2017	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE Exhibit 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per share of common stock to be paid on December 22, 2017 to all common stockholders of record as of December 1, 2017. Exponent has p
October 18, 2017	8-K	Exponent FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 18, 2017 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
October 18, 2017	8-K/A	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 18, 2017 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Num
August 4, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC
July 18, 2017	EX-99.2	Exponent Declares Regular Quarterly Dividend EdgarFiling
July 18, 2017	8-K	Exponent FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 18, 2017 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I.
July 18, 2017	EX-99.1	Exponent Reports Second Quarter Fiscal Year 2017 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Second Quarter Fiscal Year 2017 Financial Results MENLO PARK, Calif., July 18, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the second quarter ended June 30, 2017. “Exponent’s second quarter results exceeded our prior outlook. Our performance was driven by strength in our biomedical, const
June 2, 2017	8-K	Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 1, 2017 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Number) (
May 5, 2017	10-Q	Exponent FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, IN
April 19, 2017	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm EXHIBIT 99.2 EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., April 19, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per share of common stock to be paid on June 23, 2017 to all common stockholders of record as of June 9, 2017. Exponent has paid, and
April 19, 2017	EX-99.1	Exponent Reports First Quarter of Fiscal Year 2017 Financial Results EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 Exponent Reports First Quarter of Fiscal Year 2017 Financial Results MENLO PARK, Calif., April 19, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter ended March 31, 2017. “Exponent’s first quarter results were better than our prior outlook and benefited from growth in our human factors, constru
April 19, 2017	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 19, 2017 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Number)
April 18, 2017	DEF 14A	Exponent, Inc. Amended and Restated 2008 Employee Stock Purchase Plan (filed as Appendix B to the Company’s Schedule 14A on April 18, 2017). UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) x Definitive Proxy State
February 24, 2017	EX-21.1	SUBSIDIARIES OF THE COMPANY EX-21.1 2 v459491ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 SUBSIDIARIES OF THE COMPANY State or Other Jurisdiction of Incorporation or Subsidiary Incorporation or Organization Exponent B.V. Netherlands Exponent Realty LLC Delaware Exponent International Ltd. United Kingdom Exponent Science and Technology Consulting (Shanghai) Co., Ltd. China Exponent Limited Hong Kong
February 24, 2017	10-K	Exponent 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 30, 2016. OR ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission File Number 0-18655 EXPONENT, INC. (Exact nam
February 14, 2017	SC 13G/A	EXPO / Exponent, Inc. / Neuberger Berman Group LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 08)* EXPONENT INC (Name of Issuer) Common (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc
February 10, 2017	SC 13G/A	EXPO / Exponent, Inc. / VANGUARD GROUP INC Passive Investment exponentinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Exponent Inc Title of Class of Securities: Common Stock CUSIP Number: 30214U102 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designat
February 9, 2017	SC 13G/A	EXPO / Exponent, Inc. / KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8)* EXPONENT INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 30214U102 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th
February 1, 2017	EX-99.1	Exponent Reports Fourth Quarter Fiscal Year 2016 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Fourth Quarter Fiscal Year 2016 Financial Results MENLO PARK, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the fourth quarter and fiscal year ended December 30, 2016. “We are pleased that Exponent’s fourth quarter and full year 2016 results were slightly better than our pr
February 1, 2017	8-K	Exponent FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): February 1, 2017 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
February 1, 2017	EX-99.2	Exponent Increases Quarterly Dividend Payment from $0.18 to $0.21 per Share EdgarFiling
December 9, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 8, 2016 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Numbe
November 4, 2016	EX-10.46	Executive Compensation Clawback Policy (incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the fiscal period ended September 30, 2016). Exhibit 10.46 Clawback Policy This Clawback Policy (this ?Policy?) has been adopted by the Board of Directors (the ?Board?) of Exponent Inc. (the ?Company?) effective as of September 29, 2016 (the ?Effective Date?) in advance of the effective date of the final rules or regulations (?Final Regulations?) expected to be adopted by the U.S. Securities and Exchange Commission and the effective date of
November 4, 2016	10-Q	Exponent FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT
October 19, 2016	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 19, 2016 Exponent, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 0-18655 77-0218904 (State or Other Jurisdiction of Incorporation) (Commission File Number)
October 19, 2016	EX-99.1	Exponent Reports Third Quarter Fiscal Year 2016 Financial Results EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 Exponent Reports Third Quarter Fiscal Year 2016 Financial Results MENLO PARK, Calif., Oct. 19, 2016 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the third quarter ended September 30, 2016. “Exponent’s third quarter results were better than our prior outlook, but continue to be impacted by softness in a few indu
October 19, 2016	EX-99.2	Exponent Adds to Stock Repurchase Authorization and Declares Regular Quarterly Dividend EdgarFiling
August 5, 2016	10-Q	Exponent FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 1, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-18655 EXPONENT, INC.
July 29, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 29, 2016 Exponent, Inc. (Exact name of registrant as specified in its charter) Delaware 0-18655 77-0218904 (State or other jurisdiction of incorporation) (Commission File Number)
July 29, 2016	EX-99.1	Exponent Appoints Dr. Catherine Corrigan to President Exhibit 99.1 Exponent Appoints Dr. Catherine Corrigan to President MENLO PARK, Calif., July 29, 2016 Exponent, Inc. (Nasdaq:EXPO) announced today the appointment of Dr. Catherine Corrigan to the position of President, reporting to Dr. Paul Johnston, CEO. Dr. Corrigan joined Exponent?s Philadelphia office in 1996, was promoted to Principal in 2002 and to Corporate Vice President in 2005. She was pr
July 19, 2016	EX-99.2	Exponent Declares Regular Quarterly Dividend EX-99.2 3 exh992.htm PRESS RELEASE EXHIBIT 99.2 Exponent Declares Regular Quarterly Dividend MENLO PARK, Calif., July 19, 2016 (GLOBE NEWSWIRE) - Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per share of common stock to be paid on September 23, 2016 to all common stockholders of record as of September 2, 2016. Exponent has

EXPO / Exponent, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings